EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of α7-Nicotinic Acetylcholine Receptors in the Pathophysiology and Treatment of Parkinson’s Disease

Eslam ElNebrisi iD, Yosra Lozon iD, Murat Oz iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26073210 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Eslam ElNebrisi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Dubai Medical College for Girls, Dubai Medical University, Dubai 20170, United Arab Emirates. Hauptthemen laut MEDLINE: alpha7 Nicotinic Acetylcholine Receptor, Parkinson Disease. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DMU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The α7 nicotinic acetylcholine receptor (α7-nAChR) is a pivotal regulator of neurotransmission, neuroprotection, and immune modulation in the central nervous system. This review explores its structural and functional attributes, highlighting its therapeutic potential in neurodegenerative disorders, particularly Parkinson’s disease (PD). α7-nAChRs mediate synaptic plasticity, modulate inflammatory responses, and influence dopamine release, positioning them as a promising pharmacological target. Positive allosteric modulators (PAMs) enhance α7-nAChR activity mainly by reducing desensitization, offering a superior therapeutic approach compared with direct agonists. Emerging preclinical studies suggest that α7-nAChR activation mitigates dopaminergic neurodegeneration, improves L-dopa-induced dyskinesia, and reduces neuroinflammation. Despite promising findings, clinical trials have yielded mixed results, necessitating further research into optimizing α7-targeted therapies. This review underscores the significance of α7-nAChRs in PD pathophysiology and highlights future directions for their translational potential in neuroprotection and symptomatic relief.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha7 Nicotinic Acetylcholine ReceptorParkinson DiseaseHumansAnimals

Stichwörter der Autor:innen

L-dopa-induced dyskinesiaParkinson’s diseaseallosteric modulatorscholinergic systemdopamine releaseneuroinflammationneuroprotectionα7-nicotinic acetylcholine receptor

Substanzen

alpha7 Nicotinic Acetylcholine Receptor

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Dubai Medical College for Girls, Dubai Medical University, Dubai 20170, United Arab Emirates.
  • Department of Pharmaceutical Sciences, Dubai Pharmacy College for Girls, Dubai Medical University, Dubai 20170, United Arab Emirates.
  • Department of Pharmacology and Therapeutics, College of Pharmacy, Kuwait University, Safat 13110, Kuwait.

ORCID-Profile: Eslam ElNebrisi, Yosra Lozon, Murat Oz

Förderung

  • DMU

Zitieren

APA

ElNebrisi, E., Lozon, Y., & Oz, M. (2025). The Role of α7-Nicotinic Acetylcholine Receptors in the Pathophysiology and Treatment of Parkinson’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26073210

Vancouver

ElNebrisi E, Lozon Y, Oz M. The Role of α7-Nicotinic Acetylcholine Receptors in the Pathophysiology and Treatment of Parkinson’s Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26073210

BibTeX
@article{ElNebrisi2025,
  author = {ElNebrisi, Eslam and Lozon, Yosra and Oz, Murat},
  title = {The Role of α7-Nicotinic Acetylcholine Receptors in the Pathophysiology and Treatment of Parkinson’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26073210}
}
Kostenlos starten →